Is there a role for HbAlc in predicting mortality and morbidity outcomes after coronary artery bypass graft surgery?

Interactive Cardiovascular and Thoracic Surgery

Volumn 17, Issue 6, 2013, Pages 1000-1008

  Tennyson, Charlene ^a   Lee, Rebecca ^b   Attia, Rizwan ^c  

^a ULSTER HOSPITAL   (United Kingdom)

^b LONDON CHEST HOSPITAL   (United Kingdom)

^c Department of Cardiovascular Surgery and Academic Surgery Guy's and St Thoma's Hospital London ^*  (United Kingdom)

Author keywords

Cerebrovascular accident; Coronary artery bypass graft; Deep sternal wound infection; Glycosylated haemoglobin; Myocardial infarct; Superficial sternal wound infection; World Health Organization

Indexed keywords

HEMOGLOBIN A1C; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEEP STERNAL WOUND INFECTION; DIABETES MELLITUS; DISEASE ASSOCIATION; GLYCEMIC CONTROL; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION RATE; INSULIN SENSITIVITY; INTRAOPERATIVE PERIOD; LENGTH OF STAY; MEDIASTINITIS; MORBIDITY; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; STERNUM; SUPERFICIAL STERNAL WOUND INFECTION; SYSTEMATIC REVIEW; WOUND DEHISCENCE; WOUND INFECTION; BLOOD; EVIDENCE BASED MEDICINE; GLYCOSYLATED HAEMOGLOBIN; POSTOPERATIVE COMPLICATION; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS GRAFT; DEEP STERNAL WOUND INFECTION; GLYCOSYLATED HAEMOGLOBIN; MYOCARDIAL INFARCT; SUPERFICIAL STERNAL WOUND INFECTION; WORLD HEALTH ORGANIZATION;

BENCHMARKING; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LENGTH OF STAY; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84903686564     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivt351     Document Type: Article

References (12)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg 2003;2:405-9.
2. Halkos M, Puskas J, Lattouf O, Kilgo P, Kerendi F, Song H et al. Elevated preoperative hemoglobin Ale level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2008;136:631-40.
3. Halkos M, Lattouf O, Puskas J, Kilgo P, Cooper W, Morris C et al. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after artery bypass surgery. Ann Thorac Surg 2008;86:1431-7.
4. Kinoshita T, Asai T, Suzuki T, Kambara A, Matsubayashi K. Preoperative hemoglobin Alc predicts atrial fibrillation after off-pump coronary artery bypass surgery. Eur J Cardiothorac Surg 2012;41:102-7.
5. Goksedef D, Ömerolu S, Yalvaç E, Bitargil M, ipek G. Is elevated HbAlc a risk factor for infection after coronary artery bypass grafting surgery. Turk J Thorac Cardiovasc Surg 2010;18:252-8.
6. Sato H, Carvalho G, Sato T, Lattermann R, Matsukawa T, Schricker T. The association of preoperative glycaemic control, intraoperative insulin sensitivity and outcomes after cardiac surgery. J Clin Endocrinol Metab 2010;95:4338-44.
7. Matsuura K, Imamaki M, Ishida A, Shimura H, Niitsuma Y, Miyazaki M. Off-pump coronary artery bypass grafting for poorly controlled diabetic patients. Ann Thorac Surg 2009;15:18-22.
8. Hudson C, Welsby I, Philips-Bute B, Matthew J, Lutz A, Hughes C et al. Glycosylated hemoglobin levels and outcome in non-diabetic cardiac surgery patients. Can J Anesth 2010;57:565-72.
9. Knapik P, Ciesla D, Filipiak K, Knapik M, Zembala M. Prevalence and clinical significance of elevated preoperative glycosylated hemoglobin in diabetic patients scheduled for coronary artery surgery. Eur J Cardiothorac Surg 2011;39:484-9.
10. Tsuruta R, Miyauchi K, Yamamoto T, Dohi S, Tambara K, Dohi T et al. Effect of preoperative hemoglobin Ale levels on long-term outcomes for diabetic patients after off-pump coronary artery bypass grafting. J Cardiol 2011;57:181-6.
11. Alserius T, Anderson R, Hammar N, Nordqvist T, Ivert T. Elevated glycosylated haemoglobin (HbAlc) is a risk marker in coronary artery bypass surgery. Scand Cardiovasc J 2008;42:392-8.
12. McGinn J, Shariff M, Bhat T, Azab B, Molloy W, Quattrocchi E et al. Artery bypass surgery patients with no previous diabetic history. J Cardiothorac Surg 2011;6:104.